Eligibility for phase 3 clinical trials of systemic therapy in real-world patients with metastatic renal cell cancer managed in a rural region.

Saved in:
Bibliographic Details
Title: Eligibility for phase 3 clinical trials of systemic therapy in real-world patients with metastatic renal cell cancer managed in a rural region.
Authors: Nieder C; Department of Oncology and Palliative Medicine, Nordland Hospital, 8092, Bodø, Norway. carsten.nieder@nlsh.no.; Department of Clinical Medicine, Faculty of Health Sciences, University of Tromsø, 9037, Tromsö, Norway. carsten.nieder@nlsh.no., Syed MA; Department of Oncology and Palliative Medicine, Nordland Hospital, 8092, Bodø, Norway., Dalhaug A; Department of Oncology and Palliative Medicine, Nordland Hospital, 8092, Bodø, Norway.; Department of Clinical Medicine, Faculty of Health Sciences, University of Tromsø, 9037, Tromsö, Norway., Pawinski A; Department of Oncology and Palliative Medicine, Nordland Hospital, 8092, Bodø, Norway., Norum J; Department of Clinical Medicine, Faculty of Health Sciences, University of Tromsø, 9037, Tromsö, Norway.; Northern Norway Regional Health Authority Trust, 8006, Bodø, Norway.
Source: Medical oncology (Northwood, London, England) [Med Oncol] 2017 Sep; Vol. 34 (9), pp. 149. Date of Electronic Publication: 2017 Jul 26.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-131X (Electronic) Linking ISSN: 13570560 NLM ISO Abbreviation: Med Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 28748331
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Eligibility for phase 3 clinical trials of systemic therapy in real-world patients with metastatic renal cell cancer managed in a rural region.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Nieder+C%22">Nieder C</searchLink>; Department of Oncology and Palliative Medicine, Nordland Hospital, 8092, Bodø, Norway. carsten.nieder@nlsh.no.; Department of Clinical Medicine, Faculty of Health Sciences, University of Tromsø, 9037, Tromsö, Norway. carsten.nieder@nlsh.no.<br /><searchLink fieldCode="AU" term="%22Syed+MA%22">Syed MA</searchLink>; Department of Oncology and Palliative Medicine, Nordland Hospital, 8092, Bodø, Norway.<br /><searchLink fieldCode="AU" term="%22Dalhaug+A%22">Dalhaug A</searchLink>; Department of Oncology and Palliative Medicine, Nordland Hospital, 8092, Bodø, Norway.; Department of Clinical Medicine, Faculty of Health Sciences, University of Tromsø, 9037, Tromsö, Norway.<br /><searchLink fieldCode="AU" term="%22Pawinski+A%22">Pawinski A</searchLink>; Department of Oncology and Palliative Medicine, Nordland Hospital, 8092, Bodø, Norway.<br /><searchLink fieldCode="AU" term="%22Norum+J%22">Norum J</searchLink>; Department of Clinical Medicine, Faculty of Health Sciences, University of Tromsø, 9037, Tromsö, Norway.; Northern Norway Regional Health Authority Trust, 8006, Bodø, Norway.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229435512%22">Medical oncology (Northwood, London, England)</searchLink> [Med Oncol] 2017 Sep; Vol. 34 (9), pp. 149. <i>Date of Electronic Publication: </i>2017 Jul 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9435512 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1559-131X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213570560%22">13570560 </searchLink><i>NLM ISO Abbreviation: </i>Med Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=28748331
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s12032-017-1002-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 149
    Titles:
      – TitleFull: Eligibility for phase 3 clinical trials of systemic therapy in real-world patients with metastatic renal cell cancer managed in a rural region.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nieder C
      – PersonEntity:
          Name:
            NameFull: Syed MA
      – PersonEntity:
          Name:
            NameFull: Dalhaug A
      – PersonEntity:
          Name:
            NameFull: Pawinski A
      – PersonEntity:
          Name:
            NameFull: Norum J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2017 Sep
              Type: published
              Y: 2017
          Identifiers:
            – Type: issn-electronic
              Value: 1559-131X
          Numbering:
            – Type: volume
              Value: 34
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Medical oncology (Northwood, London, England)
              Type: main
ResultId 1